Pulmonx Corporation (LUNG) vs Zomedica Corp. (ZOMDF)
Pulmonx Corporation and Zomedica Corp. are both Medical Devices companies. Zomedica Corp. is the larger, with a market value of $95.4M against $81.6M — 1.2× the size. Zomedica Corp. grew revenue faster over the last twelve months: 30.1% against −3.43%. Zomedica Corp. has the higher net margin (−51.4% vs −55.0%) and the higher return on invested capital (−20.5% vs −141.0%). Across the 17 metrics below, Zomedica Corp. leads on 10 and Pulmonx Corporation on 7.
Valuation
Profitability
| Metric | LUNG | ZOMDF | Medical Devices median |
|---|---|---|---|
| Gross margin | 77.06% | 65.44% | 56.01% |
| Operating margin | (52.96%) | (56.28%) | (15.03%) |
| Net margin | (55.03%) | (51.39%) | (20.40%) |
| Free cash flow margin | (35.07%) | (40.75%) | (7.24%) |
| Return on equity | (88.87%) | (16.29%) | (15.32%) |
| Return on assets | (36.74%) | (14.88%) | (19.72%) |
| Return on invested capital | (141.03%) | (20.54%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack